Insulet Corporation (PODD) vs Smith & Nephew SNATS, Inc. (SNN)
- Insulet Corporation PODD 145.49 −6.81%
- Smith & Nephew SNATS, Inc. SNN 31.12 −2.78%
Insulet Corporation and Smith & Nephew SNATS, Inc. are both Medical Devices companies. Smith & Nephew SNATS, Inc. is the larger, with a market value of $13.4B against $10.8B — 1.2× the size. Insulet Corporation trades at the lower P/E: 25.2× against 38.9×. Insulet Corporation grew revenue faster over the last twelve months: 26.5% against 4.81%. Insulet Corporation has the higher net margin (13.5% vs 6.71%) and the higher return on invested capital (18.8% vs 0.00%). Across the 22 metrics below, Insulet Corporation leads on 15 and Smith & Nephew SNATS, Inc. on 7.
Valuation
Profitability
| Metric | PODD | SNN | Medical Devices median |
|---|---|---|---|
| Gross margin | 71.88% | 70.52% | 57.76% |
| Operating margin | 18.43% | 0.00% | (15.07%) |
| Net margin | 13.45% | 6.71% | (14.45%) |
| Free cash flow margin | 8.15% | 0.00% | (3.88%) |
| Return on equity | 28.94% | 0.00% | (10.35%) |
| Return on assets | 13.31% | 0.00% | (17.26%) |
| Return on invested capital | 18.77% | 0.00% | (5.27%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack